Article Information
History
- July 29, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Anghesom Ghebremedhin1,
- Ahmad Bin Salam1,
- Benjamin Adu-Addai2,
- Steve Noonan3,
- Richard Stratton4,
- Md. Shakir Uddin Ahmed1,
- Chandra Khantwal3,
- George R Martin5,
- Huixian Lin1,
- Chris Andrews1,
- Balasubramanyam Karanam1,
- Udo Rudloff6,
- Henry Lopez3,5,
- Jesse Jaynes7 and
- Clayton Yates1,*
- 1Department of Biology and Center for Cancer Research, Tuskegee University, Tuskegee, AL
- 2Department of Pathobiology, College of Veterinary Medicine, Tuskegee University, Tuskegee, AL
- 3Murigenics Inc., 941 Railroad Ave Vallejo, California 94592
- 4Royal Free Hospital, UCL Division of Medicine, University College London, London England
- 5Riptide Biosciences, 941 Railroad Ave Vallejo, California 94592
- 6Rare Tumor Initiative, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD
- 7College of Agriculture, Environment and Nutrition Sciences, Tuskegee University, Tuskegee AL
- ↵*Address correspondence and reprint requests to:
Clayton Yates, PhD, Department of Biology and Center for Cancer Research, Tuskegee University, Carver Research Foundation, Rm #22, Tuskegee, Alabama 36088 USA, 334-727-8949,334-727-8124 (Fax) cyates{at}tuskegee.edu, ccy3{at}uab.edu
Posted July 29, 2020.
A Novel CD206 Targeting Peptide Inhibits Bleomycin Induced Pulmonary Fibrosis in Mice
